Sale

Normal Saline for Parenteral Use Market

Global Normal Saline for Parenteral Use Market Size, Share: By Type: Plastic Bottles, Glass Bottles; By Application: Intramuscular Injection, Intravenous Injection; By End User: Hospitals, Specialty Clinics, Ambulatory Surgical Centers, Others; Regional Analysis; Market Dynamics: SWOT Analysis; Supplier Landscape; 2024-2032

Global Normal Saline for Parenteral Use Market Size

The global normal saline for parenteral use market was valued at USD 3.38 billion in 2023, due to rising incidence of chronic diseases that often involve the use of intravenous fluids like normal saline across the globe. The market is expected to grow at a CAGR of 5.50% during the forecast period of 2024-2032 with the values likely to reach USD 5.48 billion by 2032.

 

normal-saline-for-parenteral-use-market

Read more about this report - REQUEST FREE SAMPLE COPY IN PDF

 

Global Normal Saline for Parenteral Use Market Outlook

  • The ongoing investments in healthcare infrastructure, particularly in emerging markets and developing regions, contribute to improved access to medical treatments. Enhanced healthcare facilities and services support the market growth for normal saline solutions used in hospitals, clinics, and other healthcare facilities.
  • The conditions such as cardiovascular diseases, diabetes, and renal disorders necessitate frequent medical interventions and management strategies that often involve intravenous therapies. Normal saline plays a crucial role in maintaining electrolyte balance and hydration in patients with chronic illnesses and thus contributing to market growth.
  • The advances in medical technology and intravenous therapy techniques contribute to the growth of the market. These innovations improve the safety, efficacy, and administration of parenteral solutions, enhancing patient outcomes and healthcare delivery.

 

Global Normal Saline for Parenteral Use Market Overview

Normal saline for parenteral use, also known as 0.9% sodium chloride solution, is a sterile solution of sodium chloride (NaCl) in water. It is isotonic to human blood and tissues, meaning its concentration of salt matches that of the body's fluids. This makes it suitable for various medical applications. The medical uses include fluid replacement, which is used to restore fluid balance in patients who are dehydrated or experiencing fluid loss due to illness, surgery, or trauma. The solution helps maintain electrolyte levels, particularly sodium and chloride ions, essential for nerve function, muscle contraction, and cellular homeostasis. Other application includes wound care used to irrigate to cleanse and maintain moisture balance in wounds.

 

Global Normal Saline for Parenteral Use Market Growth Drivers

Increasing Surgical Volumes

The growth in surgical interventions worldwide is a significant driver for the market. Surgical procedures, both elective and emergency, often require intravenous fluids for hydration, electrolyte balance, and medication administration, thereby, boosting the demand for normal saline solutions. According to an article published by The Lancet, approximately 313 million surgical procedures undertaken worldwide each year.

 

Hence, the rise in surgical volumes leads to growth in the global normal saline market for parenteral use by increasing the demand for intravenous fluids during surgeries, supporting fluid management and electrolyte balance, facilitating surgical procedures, and aiding in postoperative recovery and thus driving the market growth.

 

Increasing Cases of Chronic Diseases is Expected to Propel Normal Saline for Parenteral Use Market Demand

The chronic diseases such as cardiovascular diseases, diabetes, kidney disorders, and respiratory conditions require ongoing medical management. Many patients with chronic illnesses require regular hospital visits, treatments, and sometimes surgeries. Normal saline is commonly used in these settings to maintain hydration, electrolyte balance, and facilitate medication administration.

 

Patients with chronic diseases often require intravenous therapies as part of their treatment regimen. Normal saline serves as a foundational fluid for these therapies, ensuring patients receive essential fluids and electrolytes to manage their conditions effectively, and thus driving the market demand.

 

normal-saline-for-parenteral-use-market-by-segments

Read more about this report - REQUEST FREE SAMPLE COPY IN PDF

 

Global Normal Saline for Parenteral Use Market Trends

The market is witnessing several trends and developments to improve the current global scenario. Some of the notable trends are as follows:

 

Key Trends Impact
Shift towards Home Healthcare There is a growing preference for home-based medical care and outpatient treatments, driven by cost-effectiveness, patient convenience, and advancements in medical technology. Normal saline, along with other intravenous fluids, is increasingly used in home healthcare settings, supported by advancements in portable infusion pumps and caregiver training and is expected to drive the market growth.
Collaborative Initiatives and Partnerships The strategic collaborations between healthcare providers, pharmaceutical companies, and medical device manufacturers aim to enhance product innovation, market penetration, and patient care outcomes. These partnerships facilitate joint research, development of advanced technologies, and geographical expansion into new markets and is acting as opportunity for the market growth.
Technological Advancements The continuous innovations in intravenous therapy devices and formulations improve the safety, efficacy, and administration of normal saline. Advanced packaging solutions, improved sterility assurance, and compatibility with medications enhance patient care and operational efficiency in healthcare settings, augmenting the market growth.

 

Global Normal Saline for Parenteral Use Market Segmentation

Market Breakup by Type
 

  • Plastic Bottles
  • Glass Bottles

 

Market Breakup by Application

  • Intramuscular Injection
  • Intravenous Injection

 

Market Breakup by End User

  • Hospitals
  • Specialty Clinics
  • Ambulatory Surgery Centers
  • Others

 

Market Breakup by Region

  • North America
  • Europe
  • Asia Pacific
  • Latin America
  • Middle East and Africa

 

Global Normal Saline for Parenteral Use Market Share

Market Segmentation Based on Type is Anticipated to Witness Substantial Growth

By type, the market is segmented into plastic bottles and glass bottles. The plastic bottles segment is expected to hold a major share as plastic bottles are they are more compatible with modern healthcare practices such as automated filling lines and logistics systems. They can be manufactured in a way that ensures sterility and prevents leaching of harmful substances into the saline solution.

 

normal-saline-for-parenteral-use-market-by-region

Read more about this report - REQUEST FREE SAMPLE COPY IN PDF

 

Global Normal Saline for Parenteral Use Market Analysis by Region

Based on the region, the market report covers North America, Europe, Asia Pacific, Latin America, and the Middle East and Africa. North America is dominating the market share as the aging population in North America, coupled with increasing chronic diseases and surgical procedures, has led to a higher demand for medical supplies, including normal saline. This demographic trend drives market regional growth as healthcare facilities stock up on essential supplies.

 

Europe also holds a high normal saline for parenteral use market value as advances in medical technology and manufacturing processes contribute to the growth of the normal saline market in Europe. Innovations in packaging, formulation, and delivery systems enhance the usability, efficiency, and safety of parenteral solutions, meeting the evolving needs of healthcare providers and thus driving the market’s growth.

 

Additionally, Asia Pacific is expected to witness substantial market growth as APAC countries are witnessing a significant increase in surgical volumes due to population growth, aging demographics, and the epidemiological transition towards non-communicable diseases which requires high demand for normal saline for parenteral use and driving the market growth.

 

Leading Players in the Global Normal Saline for Parenteral Use Market

The key features of the market report include strategic initiatives such as recent partnerships, and collaborations analysis by the leading key players. The major companies in the market are as follows:

 

Baxter International, Inc.

Baxter International is one of the leading manufacturers and suppliers of normal saline solutions globally. The company's extensive portfolio includes a range of intravenous solutions, including 0.9% Sodium Chloride (normal saline), which is widely used in healthcare settings for hydration, medication administration, and various medical procedures.

 

Pfizer, Inc.

Pfizer, Inc. a leading provider of injectable drugs and infusion technologies and well-known for its portfolio of intravenous solutions, including normal saline (0.9% Sodium Chloride).

 

Otsuka Pharmaceutical Co., Ltd.

Otsuka Pharmaceutical Factory, Inc. manufactures and supplies a range of intravenous solutions, including normal saline (0.9% Sodium Chloride). These products are critical in healthcare settings for fluid and electrolyte replenishment, medication administration, and other medical procedures.

 

Other key players in the market include ICU Medical, Inc., Sichuan Kelun Pharmaceutical Co., Ltd., B. Braun Melsungen AG, Alcare pharmaceuticals pte Ltd, SOXA FORMULATIONS & RESEARCH PVT. LTD., NIRMA LIMITED, and Advacare Pharma USA, LLC. among others.

 

Kindly note that this only represents a partial list of companies and the complete list has been in the report.

 

Key Highlights of the Report

REPORT FEATURES DETAILS
Base Year 2023
Historical Period 2017-2023
Forecast Period 2024-2032
Scope of the Report

Historical and Forecast Trends, Industry Drivers and Constraints, Historical and Forecast Market Analysis by Segment:

  • Type
  • Application
  • End User
  • Region
Breakup by Type
  • Plastic Bottles
  • Glass Bottles
Breakup by Application
  • Intramuscular Injection
  • Intravenous Injection
Breakup by End User
  • Hospitals
  • Specialty Clinics
  • Ambulatory Surgical Centers
  • Others
Breakup by Region
  • North America
  • Europe
  • Asia Pacific
  • Latin America
  • Middle East and Africa
Market Dynamics
  • Market Drivers and Constraints
  • SWOT Analysis
  • Porter’s Five Forces Model 
  • Key Demand Indicators
  • Key Price Indicators
  • Industry Events, Initiatives, and Trends 
  • Value Chain Analysis
Supplier Landscape
  • Market Structure
  • Company Profiles
    • Financial Analysis
    • Product Portfolio
    • Demographic Reach and Achievements
    • Mergers and Acquisitions
    • Certifications
Companies Covered
  • Baxter International, Inc.
  • Pfizer Inc.
  • Otsuka Pharmaceutical Co.
  • ICU Medical, Inc.
  • Sichuan Kelun Pharmaceutical Co., Ltd. 
  • B. Braun Melsungen AG
  • Alcare pharmaceuticals pte ltd
  • SOXA FORMULATIONS & RESEARCH PVT. LTD. 
  • NIRMA LIMITED
  • Advacare Pharma USA, LLC.

 

Key Questions Answered in the Global Normal Saline for Parenteral Use Market Report

  • What was the global normal saline for parenteral use market value in 2023?
  • What is the global normal saline for parenteral use market forecast outlook for 2024-2032?
  • What are the regional markets covered in the EMR report?
  • What is market segmentation based on type?
  • What is market segmentation based on application?
  • What is market segmentation based on end user?
  • What are the major factors aiding the global normal saline for parenteral use market demand? 
  • How has the market performed so far and how is it anticipated to perform in the coming years?
  • What are the major market trends influencing the market? 
  • What are the market's major drivers, opportunities, and restraints? 
  • Which regional market is expected to lead the market share in the forecast period? 
  • Which country is expected to experience expedited growth during the forecast period? 
  • How does the growing cases of chronic diseases impact the market size?
  • Who are the key players involved in the normal saline for parenteral use market?
  • What are the current unmet needs and challenges in the market?
  • How are partnerships, collaborations, mergers and acquisitions among the key market players shaping the market dynamics?

 

*While we strive to always give you current and accurate information, the numbers depicted on the website are indicative and may differ from the actual numbers in the main report. At Expert Market Research, we aim to bring you the latest insights and trends in the market. Using our analyses and forecasts, stakeholders can understand the market dynamics, navigate challenges, and capitalize on opportunities to make data-driven strategic decisions.

1    Preface
    1.1    Objectives of the Study
    1.2    Key Assumptions
    1.3    Report Coverage – Key Segmentation and Scope 
    1.4    Research Methodology
2    Executive Summary
3    Global Normal  Saline for Parenteral Use Market Overview 

    3.1    Global Normal Saline for Parenteral Use Market Historical Value (2017-2023) 
    3.2    Global Normal Saline for Parenteral Use Market Forecast Value (2024-2032)
4    Vendor Positioning Analysis
    4.1    Key Vendors
    4.2    Prospective Leaders
    4.3    Niche Leaders
    4.4    Disruptors
5    Global Normal Saline for Parenteral Use Market Landscape*
    5.1    Global Normal Saline for Parenteral Use: Developers Landscape
        5.1.1    Analysis by Year of Establishment
        5.1.2    Analysis by Company Size
        5.1.3    Analysis by Region
    5.2    Global Normal Saline for Parenteral Use: Product Landscape 
        5.2.1    Analysis by Type
        5.2.2    Analysis by Volume/size
6    Global Normal Saline for Parenteral Use Market Dynamics
    6.1    Market Drivers and Constraints
    6.2    SWOT Analysis
        6.2.1    Strengths
        6.2.2    Weaknesses
        6.2.3    Opportunities
        6.2.4    Threats
    6.3    PESTEL Analysis 
        6.3.1    Political 
        6.3.2    Economic 
        6.3.3    Social 
        6.3.4    Technological 
        6.3.5    Legal 
        6.3.6    Environment 
    6.4    Porter’s Five Forces Model
        6.4.1    Bargaining Power of Suppliers
        6.4.2    Bargaining Power of Buyers
        6.4.3    Threat of New Entrants
        6.4.4    Threat of Substitutes
        6.4.5    Degree of Rivalry
    6.5    Key Demand Indicators 
    6.6    Key Price Indicators
    6.7    Industry Events, Initiatives, and Trends  
    6.8    Value Chain Analysis
7    Global Normal  Saline for Parenteral Use Market Segmentation (2017-2032)
    7.1    Global Normal Saline for Parenteral Use Market (2017-2032) by Type
        7.1.1    Market Overview
        7.1.2    Plastic Bottles
        7.1.3    Glass Bottles
    7.2    Global Normal Saline for Parenteral Use Market (2017-2032) by Application
        7.2.1    Market Overview
        7.2.2    Intramuscular Injection
        7.2.3    Intravenous Injection
    7.3    Global Normal Saline for Parenteral Use Market (2017-2032) by End User
        7.3.1    Market Overview
        7.3.2    Hospitals
        7.3.3    Specialty Clinics
        7.3.4    Ambulatory Surgical Centers
        7.3.5    Others
    7.4    Global Normal Saline for Parenteral Use Market (2017-2032) by Region
        7.4.1    Market Overview
        7.4.2    North America
        7.4.3    Europe 
        7.4.4    Asia Pacific
        7.4.5    Latin America
        7.4.6    Middle East and Africa
8    North America Normal Saline for Parenteral Use Market (2017-2032)
    8.1    North America Normal Saline for Parenteral Use Market (2017-2032) by Type
        8.1.1    Market Overview
        8.1.2    Plastic Bottles
        8.1.3    Glass Bottles
    8.2    North America Normal Saline for Parenteral Use Market (2017-2032) by Application
        8.2.1    Market Overview
        8.2.2    Intramuscular Injection
        8.2.3    Intravenous Injection
    8.3    North America Normal Saline for Parenteral Use Market (2017-2032) by End User
        8.3.1    Market Overview
        8.3.2    Hospitals
        8.3.3    Specialty Clinics
        8.3.4    Ambulatory Surgical Centers
        8.3.5    Others 
    8.4    North America Normal Saline for Parenteral Use Market (2017-2032) by Country
        8.4.1    United States of America
        8.4.2    Canada
9    Europe Normal Saline for Parenteral Use Market (2017-2032)
    9.1    Europe Normal Saline for Parenteral Use Market (2017-2032) by Type
        9.1.1    Market Overview
        9.1.2    Plastic Bottles
        9.1.3    Glass Bottles
    9.2    Europe Normal Saline for Parenteral Use Market (2017-2032) by Application
        9.2.1    Market Overview
        9.2.2    Intramuscular Injection
        9.2.3    Intravenous Injection
    9.3    Europe Normal Saline for Parenteral Use Market (2017-2032) by End User
        9.3.1    Market Overview
        9.3.2    Hospitals
        9.3.3    Specialty Clinics
        9.3.4    Ambulatory Surgical Centers
        9.3.5    Others 
    9.4    Europe Normal Saline for Parenteral Use Market (2017-2032) by Country
        9.4.1    United Kingdom
        9.4.2    Germany
        9.4.3    France
        9.4.4    Italy
        9.4.5    Others
10    Asia Pacific  Normal Saline for Parenteral Use Market (2017-2032)
    10.1    Asia Pacific Normal Saline for Parenteral Use Market (2017-2032) by Type
        10.1.1    Market Overview
        10.1.2    Plastic Bottles
        10.1.3    Glass Bottles
    10.2    Asia Pacific Normal Saline for Parenteral Use Market (2017-2032) by Application
        10.2.1    Market Overview
        10.2.2    Intramuscular Injection
        10.2.3    Intravenous Injection
    10.3    Asia Pacific Normal Saline for Parenteral Use Market (2017-2032) by End User
        10.3.1    Market Overview
        10.3.2    Hospitals
        10.3.3    Specialty Clinics
        10.3.4    Ambulatory Surgical Centers
        10.3.5    Others 
    10.4    Asia Pacific Normal Saline for Parenteral Use Market (2017-2032) by Country
        10.4.1    China
        10.4.2    Japan
        10.4.3    India
        10.4.4    ASEAN
        10.4.5    Australia
        10.4.6    Others
11    Latin America  Normal Saline for Parenteral Use Market (2017-2032)
    11.1    Latin America Normal Saline for Parenteral Use Market (2017-2032) by Type
        11.1.1    Market Overview
        11.1.2    Plastic Bottles
        11.1.3    Glass Bottles
    11.2    Latin America Normal Saline for Parenteral Use Market (2017-2032) by Application
        11.2.1    Market Overview
        11.2.2    Intramuscular Injection
        11.2.3    Intravenous Injection
    11.3    Latin America Normal Saline for Parenteral Use Market (2017-2032) by End User
        11.3.1    Market Overview
        11.3.2    Hospitals
        11.3.3    Specialty Clinics
        11.3.4    Ambulatory Surgical Centers
        11.3.5    Others 
    11.4    Latin America Normal Saline for Parenteral Use Market (2017-2032) by Country
        11.4.1    Brazil
        11.4.2    Argentina
        11.4.3    Mexico
        11.4.4    Others
12    Middle East and Africa Normal Saline for Parenteral Use Market (2017-2032)
    12.1     Middle East and Africa Normal Saline for Parenteral Use Market (2017-2032) by Sensor Type
        12.1.1    Market Overview
        12.1.2    Plastic Bottles
        12.1.3    Glass Bottles
    12.2    Middle East and Africa Normal Saline for Parenteral Use Market (2017-2032) by Application
        12.2.1    Market Overview
        12.2.2    Intramuscular Injection
        12.2.3    Intravenous Injection
    12.3     Middle East and Africa Normal Saline for Parenteral Use Market (2017-2032) by End User
        12.3.1    Market Overview
        12.3.2    Hospitals
        12.3.3    Specialty Clinics
        12.3.4    Ambulatory Surgical Centers
        12.3.5    Others 
    12.4    Middle East and Africa Normal Saline for Parenteral Use Market (2017-2032) by Country
        12.4.1    Saudi Arabia
        12.4.2    United Arab Emirates
        12.4.3    Nigeria
        12.4.4    South Africa
        12.4.5    Others
13    Regulatory Framework
    13.1    Regulatory Overview
    13.2    US FDA
    13.3    EU EMA
    13.4    INDIA CDSCO
    13.5    JAPAN PMDA
    13.6    Others
14    Supplier Landscape
    14.1    Market Share Analysis, By Region (Top 5 Companies)
        14.1.1    Market Share Analysis: Global
        14.1.2    Market Share Analysis: North America
        14.1.3    Market Share Analysis: Europe
        14.1.4    Market Share Analysis: Asia-Pacific
        14.1.5    Market Share Analysis: Others
    14.2    Baxter International, Inc.
        14.2.1    Financial Analysis
        14.2.2    Product Portfolio
        14.2.3    Demographic Reach and Achievements
        14.2.4    Mergers and Acquisitions
        14.2.5    Certifications 
    14.3    Pfizer Inc.
        14.3.1    Financial Analysis
        14.3.2    Product Portfolio
        14.3.3    Demographic Reach and Achievements
        14.3.4    Mergers and Acquisitions
        14.3.5    Certifications
    14.4    Otsuka Pharmaceutical Co.
        14.4.1    Financial Analysis
        14.4.2    Product Portfolio
        14.4.3    Demographic Reach and Achievements
        14.4.4    Mergers and Acquisitions
        14.4.5    Certifications
    14.5    ICU Medical, Inc.
        14.5.1    Financial Analysis
        14.5.2    Product Portfolio
        14.5.3    Demographic Reach and Achievements
        14.5.4    Mergers and Acquisitions
        14.5.5    Certifications
    14.6    Sichuan Kelun Pharmaceutical Co., Ltd. 
        14.6.1    Financial Analysis
        14.6.2    Product Portfolio
        14.6.3    Demographic Reach and Achievements
        14.6.4    Mergers and Acquisitions
        14.6.5    Certifications
    14.7    B. Braun Melsungen AG
        14.7.1    Financial Analysis
        14.7.2    Product Portfolio
        14.7.3    Demographic Reach and Achievements
        14.7.4    Mergers and Acquisitions
        14.7.5    Certifications
    14.8    Alcare pharmaceuticals pte ltd
        14.8.1    Financial Analysis
        14.8.2    Product Portfolio
        14.8.3    Demographic Reach and Achievements
        14.8.4    Mergers and Acquisitions
        14.8.5    Certifications
    14.9    SOXA FORMULATIONS & RESEARCH PVT. LTD. 
        14.9.1    Financial Analysis
        14.9.2    Product Portfolio
        14.9.3    Demographic Reach and Achievements
        14.9.4    Mergers and Acquisitions
        14.9.5    Certifications 
    14.10    NIRMA LIMITED
        14.10.1    Financial Analysis
        14.10.2    Product Portfolio
        14.10.3    Demographic Reach and Achievements
        14.10.4    Mergers and Acquisitions
        14.10.5    Certifications 
    14.11    Advacare Pharma USA, LLC. 
        14.11.1    Financial Analysis
        14.11.2    Product Portfolio
        14.11.3    Demographic Reach and Achievements
        14.11.4    Mergers and Acquisitions
        14.11.5    Certifications
15    Global Normal Saline for Parenteral Use Market – Distribution Model (Additional Insight)
    15.1     Overview 
    15.2     Potential Distributors 
    15.3     Key Parameters for Distribution Partner Assessment 
16    Key Opinion Leaders (KOL) Insights (Additional Insight)

 

*Additional insights provided are customisable as per client requirements.

 

* The coverage of the Market Landscape section depends on the data availability and may cover a minimum of 80% of the total market. The EMR team strives to make this section as comprehensive as possible.

 

**The supplier list is not exhaustive, moreover we can provide analysis of companies as per custom request.

Purchase Full Report

Mini Report

$ 2969     $2699
  • Selected Sections, One User
  • Printing Not Allowed
  • Email Delivery in PDF
  • Free Limited Customisation
  • Post Sales Analyst Support
  • 50% Discount on Next Update

Single User License

$ 5499     $4999
  • All Sections, One User
  • One Print Allowed
  • Email Delivery in PDF
  • Free Limited Customisation
  • Post Sales Analyst Support
  • 50% Discount on Next Update
most popular

Five User License

$ 6599     $5999
  • All Sections, Five Users
  • Five Prints Allowed
  • Email Delivery in PDF
  • Free Limited Customisation
  • Post Sales Analyst Support
  • 50% Discount on Next Update

Corporate License

$ 7699     $6999
  • All Sections, Unlimited Users
  • Unlimited Prints Allowed
  • Email Delivery in PDF + Excel
  • Free Limited Customisation
  • Post Sales Analyst Support
  • 50% Discount on Next Update

Any Question? Speak With An Analyst

Contact Analyst

View A Sample

Request Sample

Did You Miss Anything, Ask Now

Request Customisation
Why Expert Market Research?

Right People

We are technically excellent, strategic, practical, experienced and efficient; our analysts are hand-picked based on having the right attributes to work successfully and execute projects based on your expectations.

Right Methodology

We leverage our cutting-edge technology, our access to trusted databases, and our knowledge of the current models used in the market to deliver you research solutions that are tailored to your needs and put you ahead of the curve.

Right Price

We deliver in-depth and superior quality research in prices that are reasonable, unmatchable, and shows our understanding of your resource structure. We, additionally, offer attractive discounts on our upcoming reports.

Right Support

Our team of expert analysts are at your beck and call to deliver you optimum results that are customised to meet your precise needs within the specified timeframe and help you form a better understanding of the industry.

NEWSLETTER